< Back to companies

COVID-19

NY

Doctors make decision-assisting bots for doctors

Share
Shareable draft
Get Involved in COVID-19

How We Help

Company Info

Clinical & IP

🔬

Clinical Validation

<p>As discussed in a previous section, we have initiated an extensive clinical trial of our software at Englewood Hospital to test avoMD&rsquo;s usability as well as its impact on outcomes for preoperative cardiac risk assessment. The first phase of our testing focused on usability, where our app was received an 87 on the System Usability Scoring (&quot;SUS&quot;) scale which ranks in the top 10% of usability for technology, beating Gmail.com (84 SUS)&nbsp;and Amazon.com (82 SUS). Additionally, 11 of 12 subjects agreed&nbsp;that the app was comprehensive enough to replace status quo tools. The next phase, a randomized control trial, was approved by an IRB in August and will measure impact on outcomes - specifically accuracy of diagnosis and physician efficiency. This phase is led by Dr. Sarah Collins (Columbia University Medical Center).&nbsp;</p> <p>We also have a preliminary agreement in place with a hospital in the Tristate area to initiate an IRB-approved clinical trial for&nbsp;our app in the neurology setting.</p>

🛡️

IP Protection

—

Only accessible to MedStartr community members. Join now

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Sign in to join the conversation.

Sign in to comment
Be the first to comment.

What do you think of COVID-19?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Your scores and comments are shown with your review on this company's profile.

Get Involved in COVID-19
💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free